Antipsychotic Efficacy and Safety of LB-102 in the Treatment of Adults With Acute Schizophrenia: A Randomized - Quiz - MDSpire

Antipsychotic Efficacy and Safety of LB-102 in the Treatment of Adults With Acute Schizophrenia: A Randomized

  • By

  • Anna Eramo

  • Christoph U. Correll

  • David P. Walling

  • Rishi Kakar

  • Niccolo Bassani

  • Leslie Callahan

  • Baker P. Lee

  • Zachary Prensky

  • Andrew R. Vaino

  • John M. Kane

  • July 1, 2026

  • 0 min

Share

Original Source(s)

Antipsychotic Efficacy and Safety of LB-102 in the Treatment of Adults With Acute Schizophrenia: A Randomized

  • by Anna Eramo, Christoph U. Correll, David P. Walling, Rishi Kakar, Niccolo Bassani, Leslie Callahan, Baker P. Lee, Zachary Prensky, Andrew R. Vaino, John M. Kane

  • July 1, 2026

Related Content

The many manifestations of magical thinking: a systematic review

Family psychoeducation to support patients with psychotic illness: two-year outcomes from a pre–post longitudinal pilot study

An interpretable TimeMIL framework for fNIRS: differential diagnosis between schizophrenia and bipolar disorder